Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

164 – The Doxy-PEP Continuum Among Patients Receiving Care at a Sexual Health Clinic in San Francisco

By Jimmy He PharmD, DScMarch 20, 2025

…we restricted to those with (1) a doxy-PEP indication. We then estimated the proportion who (2) received a doxy-PEP prescription; (3) initiated (i.e. self-reported ever taking) doxy-PEP; and (4) adhered…

1020 – Projected Impact of Doxycycline PEP on Syphilis Incidence: Modeling Study in 4 US Cities

By Jimmy He PharmD, DScMarch 31, 2026

…(2) 10% doxy-PEP uptake among MSM by 2027; (3) 25% doxy-PEP by 2027. We assumed doxy-PEP efficacy ranged from 52% to 92%, consistent with clinical trials. The primary outcomes include…

Early Adopters: Implementation of Doxycycline Postexposure Prophylaxis in a Boston Health Center

By Jimmy He PharmD, DScMarch 6, 2024

…randomized trials that enrolled cisgender men who have sex with men (MSM) and transgender women. However, limited data are available to inform the implementation of this novel STI prevention intervention…

1284 – Antimicrobial Consumption Among Users of Doxycycline Post-Exposure Prophylaxis in Milan, Italy

By Jimmy He PharmD, DScMarch 18, 2025

…prophylaxis (DoxyPEP) among men who have sex with men (MSM). Methods Retrospective study of MSM in care for HIV or HIV pre-exposure prophylaxis (PrEP) at the Infectious Diseases Unit of…

1276 – Doxycycline Post-Exposure Prophylaxis Continuum of Care Among MSM in Philadelphia, 2023

By Jimmy He PharmD, DScMarch 20, 2025

Background Doxycycline post-exposure prophylaxis (Doxy-PEP) is an effective tool for reducing bacterial sexually transmitted infection (STI) incidence among men who have sex with men (MSM). We sought to understand current…

Implementation of DoxyPEP: Challenges and Opportunities

By Jimmy He PharmD, DScApril 26, 2024

Presentation: Doxycycline post-exposure prophylaxis (doxy-PEP) is highly effective in reducing bacterial STIs among men who have sex with men (MSM) and transgender women (TGW). Optimizing the public health impact of…

PrEP Following PEP: An Effective HIV Risk-Reduction Strategy

By Jimmy He PharmD, DScMarch 6, 2024

…transwomen attending our service for PEP and their subsequent PrEP follow-up. Methods: We performed a case note review of PEPSE recipients at our service from 1st March to 30th April…

Instability of the HLA-E Peptidome of HIV Presents a Major Barrier to Therapeutic Targeting

By Jimmy He PharmD, DScMarch 6, 2024

…Gag275-283 by HLA-E was only demonstrated when peptide was supplied exogenously (peptide pulsing model). Only sporadic and inconsistent peptide presentation was detected when the peptide source was endogenously expressed HIV…

HIV INCIDENCE AMONG MSM GIVEN PEP STARTER PACKS IN NYC SEXUAL HEALTH CLINICS, 2014-16

By Enthusiast Inc MDMarch 6, 2018

…and HIV incidence in patients receiving HIV PEP starter packs. We analyzed data on HIV-negative men who have sex with men (MSM) who received PEP starter packs at NYC sexual…

HIV Post-Exposure Prophylaxis Prescription Trends: United States, 2013-2022

By Jimmy He PharmD, DScMarch 6, 2024

…U.S. population-level estimates of PEP are lacking. Our objective was to estimate trends in the number of persons prescribed PEP and compare with PrEP trends. Methods: We analyzed data from…

←123456…
78910111213141516171819202122232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top